Skandinaviska Enskilda Banken (SEB)
JBIO

Skandinaviska Enskilda Banken (SEB)’s Jade Biosciences JBIO Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,266
Closed -$1.31M – 770
2024
Q1 		$1.31M Sell
1,266
-187
-13% -$143K 0.01% 639
2023
Q4 		$1.15M Hold
1,453
– – 0.01% 678
2023
Q3 		$690K Hold
1,453
– – ﹤0.01% 729
2023
Q2 		$872K Hold
1,453
– – 0.01% 720
2023
Q1 		$1.03M Sell
1,453
-71
-5% -$58.9K 0.01% 684
2022
Q4 		$1.56M Sell
1,524
-88
-5% -$63.9K 0.01% 594
2022
Q3 		$936K Hold
1,612
– – 0.01% 692
2022
Q2 		$882K Buy
1,612
+1,209
+300% +$577K 0.01% 730
2022
Q1 		$259K Buy
+403
New +$156K ﹤0.01% 876

Other funds holding JBIO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s JBIO Position: Q2 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Jade Biosciences (JBIO) in Q2 2024, closing a stake of 1,266 shares — an estimated $1.31M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in JBIO in Q1 2022 and held it in 9 quarters. The position peaked at $1.56M in Q4 2022. 80 funds tracked by Wall St. Rank hold JBIO as of Q2 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Jade Biosciences position as of Q2 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 1,266 Jade Biosciences shares in Q2 2024, an estimated $1.31M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Jade Biosciences in Q1 2022 and held it in 9 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Jade Biosciences position peaked at $1.56M in Q4 2022.
  • 80 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2024, filed 13 Aug 2024.